

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.58519363 |
| 2 | definitive hemopoiesis (GO:0060216) | 4.13097988 |
| 3 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.80628845 |
| 4 | embryonic process involved in female pregnancy (GO:0060136) | 3.77898261 |
| 5 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.72567570 |
| 6 | histone H3-K9 demethylation (GO:0033169) | 3.71977284 |
| 7 | histone lysine demethylation (GO:0070076) | 3.64558655 |
| 8 | histone H3-K36 demethylation (GO:0070544) | 3.62115162 |
| 9 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.59128700 |
| 10 | histone demethylation (GO:0016577) | 3.54768516 |
| 11 | receptor recycling (GO:0001881) | 3.52860601 |
| 12 | megakaryocyte development (GO:0035855) | 3.48420883 |
| 13 | fibroblast migration (GO:0010761) | 3.48005599 |
| 14 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.43048915 |
| 15 | erythrocyte development (GO:0048821) | 3.40514407 |
| 16 | protein demethylation (GO:0006482) | 3.39552834 |
| 17 | protein dealkylation (GO:0008214) | 3.39552834 |
| 18 | negative regulation of histone methylation (GO:0031061) | 3.33704662 |
| 19 | negative regulation of glial cell proliferation (GO:0060253) | 3.33117182 |
| 20 | microglial cell activation (GO:0001774) | 3.27026279 |
| 21 | hepatocyte apoptotic process (GO:0097284) | 3.26007340 |
| 22 | corticosteroid receptor signaling pathway (GO:0031958) | 3.24274364 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.22594007 |
| 24 | positive regulation of receptor recycling (GO:0001921) | 3.19813455 |
| 25 | positive regulation of histone deacetylation (GO:0031065) | 3.19552496 |
| 26 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.19060326 |
| 27 | regulation of protein polyubiquitination (GO:1902914) | 3.18827400 |
| 28 | nuclear pore complex assembly (GO:0051292) | 3.17883734 |
| 29 | hemoglobin metabolic process (GO:0020027) | 3.16466087 |
| 30 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.14455815 |
| 31 | embryonic camera-type eye morphogenesis (GO:0048596) | 3.11320469 |
| 32 | embryonic hemopoiesis (GO:0035162) | 3.08899068 |
| 33 | negative regulation of histone modification (GO:0031057) | 3.07652019 |
| 34 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.06424926 |
| 35 | pre-miRNA processing (GO:0031054) | 3.05683305 |
| 36 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.05222486 |
| 37 | dosage compensation (GO:0007549) | 3.02471619 |
| 38 | detection of molecule of bacterial origin (GO:0032490) | 2.98566671 |
| 39 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.98112316 |
| 40 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.98112316 |
| 41 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.98112316 |
| 42 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.96886012 |
| 43 | histone H3-K4 trimethylation (GO:0080182) | 2.93637189 |
| 44 | cellular response to epinephrine stimulus (GO:0071872) | 2.91436790 |
| 45 | iron ion import (GO:0097286) | 2.91360886 |
| 46 | nuclear pore organization (GO:0006999) | 2.90367538 |
| 47 | erythrocyte maturation (GO:0043249) | 2.89169756 |
| 48 | growth hormone receptor signaling pathway (GO:0060396) | 2.87015578 |
| 49 | macroautophagy (GO:0016236) | 2.85484594 |
| 50 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.83015169 |
| 51 | negative regulation of neurotransmitter transport (GO:0051589) | 2.82871750 |
| 52 | histone H3-K4 methylation (GO:0051568) | 2.81383959 |
| 53 | negative regulation of DNA repair (GO:0045738) | 2.78701694 |
| 54 | oxygen transport (GO:0015671) | 2.78053556 |
| 55 | protein K11-linked deubiquitination (GO:0035871) | 2.74301127 |
| 56 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.72798607 |
| 57 | myeloid cell development (GO:0061515) | 2.71504147 |
| 58 | embryonic eye morphogenesis (GO:0048048) | 2.71001577 |
| 59 | negative regulation of chromatin modification (GO:1903309) | 2.70794787 |
| 60 | response to methylmercury (GO:0051597) | 2.70663143 |
| 61 | positive regulation of p38MAPK cascade (GO:1900745) | 2.69864296 |
| 62 | regulation of translational termination (GO:0006449) | 2.69285944 |
| 63 | positive regulation of protein deacetylation (GO:0090312) | 2.67887240 |
| 64 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.66255534 |
| 65 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.66255534 |
| 66 | macrophage activation (GO:0042116) | 2.65560221 |
| 67 | nerve growth factor signaling pathway (GO:0038180) | 2.64755940 |
| 68 | embryonic placenta development (GO:0001892) | 2.63299333 |
| 69 | mitotic sister chromatid cohesion (GO:0007064) | 2.62829411 |
| 70 | regulation of beta-amyloid formation (GO:1902003) | 2.61346212 |
| 71 | import into cell (GO:0098657) | 2.61288776 |
| 72 | tetrapyrrole biosynthetic process (GO:0033014) | 2.61087711 |
| 73 | neutrophil mediated immunity (GO:0002446) | 2.57993199 |
| 74 | gas transport (GO:0015669) | 2.57792585 |
| 75 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.57553079 |
| 76 | mitotic chromosome condensation (GO:0007076) | 2.56378645 |
| 77 | cardiac myofibril assembly (GO:0055003) | 2.55952727 |
| 78 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.55372291 |
| 79 | regulation of response to osmotic stress (GO:0047484) | 2.54133183 |
| 80 | positive regulation of mRNA catabolic process (GO:0061014) | 2.53709070 |
| 81 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.52817717 |
| 82 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.51994237 |
| 83 | negative regulation of fatty acid transport (GO:2000192) | 2.51722779 |
| 84 | pore complex assembly (GO:0046931) | 2.51024594 |
| 85 | negative regulation of histone acetylation (GO:0035067) | 2.49428055 |
| 86 | regulation of p38MAPK cascade (GO:1900744) | 2.49075510 |
| 87 | paraxial mesoderm development (GO:0048339) | 2.48999124 |
| 88 | regulation of necroptotic process (GO:0060544) | 2.48885582 |
| 89 | regulation of glial cell proliferation (GO:0060251) | 2.47392604 |
| 90 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.47052593 |
| 91 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.46882190 |
| 92 | erythrocyte differentiation (GO:0030218) | 2.46765472 |
| 93 | regulation of histone H3-K9 methylation (GO:0051570) | 2.45678379 |
| 94 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.43223323 |
| 95 | sister chromatid segregation (GO:0000819) | 2.41024235 |
| 96 | cellular extravasation (GO:0045123) | 2.40465149 |
| 97 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.39439549 |
| 98 | cerebellar granule cell differentiation (GO:0021707) | 2.38645194 |
| 99 | histone H2A monoubiquitination (GO:0035518) | 2.38503576 |
| 100 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.37490006 |
| 101 | cellular response to growth hormone stimulus (GO:0071378) | 2.37449428 |
| 102 | myeloid leukocyte mediated immunity (GO:0002444) | 2.36459347 |
| 103 | macrophage activation involved in immune response (GO:0002281) | 2.36381467 |
| 104 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.35954630 |
| 105 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.35808347 |
| 106 | mRNA stabilization (GO:0048255) | 2.35271938 |
| 107 | RNA stabilization (GO:0043489) | 2.35271938 |
| 108 | regulation of ARF protein signal transduction (GO:0032012) | 2.35257266 |
| 109 | response to epinephrine (GO:0071871) | 2.34317615 |
| 110 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.34211076 |
| 111 | negative regulation of hormone metabolic process (GO:0032351) | 2.34211076 |
| 112 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.33525258 |
| 113 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.33525258 |
| 114 | regulation of platelet aggregation (GO:0090330) | 2.31899229 |
| 115 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 2.30112100 |
| 116 | gene silencing by RNA (GO:0031047) | 2.30042379 |
| 117 | hemopoiesis (GO:0030097) | 2.29081095 |
| 118 | cellular response to ethanol (GO:0071361) | 2.28586844 |
| 119 | histone lysine methylation (GO:0034968) | 2.28345264 |
| 120 | sister chromatid cohesion (GO:0007062) | 2.28183185 |
| 121 | mitotic sister chromatid segregation (GO:0000070) | 2.27426471 |
| 122 | negative regulation of inclusion body assembly (GO:0090084) | 2.27215975 |
| 123 | protein K48-linked deubiquitination (GO:0071108) | 2.27125755 |
| 124 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.27088097 |
| 125 | cellular response to catecholamine stimulus (GO:0071870) | 2.26239200 |
| 126 | cellular response to monoamine stimulus (GO:0071868) | 2.26239200 |
| 127 | demethylation (GO:0070988) | 2.25860284 |
| 128 | porphyrin-containing compound metabolic process (GO:0006778) | 2.25149417 |
| 129 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.24159040 |
| 130 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.24112449 |
| 131 | * regulation of erythrocyte differentiation (GO:0045646) | 2.23689986 |
| 132 | actin filament capping (GO:0051693) | 2.23432600 |
| 133 | platelet formation (GO:0030220) | 2.23412195 |
| 134 | regulation of mRNA catabolic process (GO:0061013) | 2.22230515 |
| 135 | negative regulation of granulocyte differentiation (GO:0030853) | 2.21754480 |
| 136 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.21754203 |
| 137 | regulation of sister chromatid cohesion (GO:0007063) | 2.21319328 |
| 138 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.20856673 |
| 139 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.20815197 |
| 140 | striated muscle atrophy (GO:0014891) | 2.20151659 |
| 141 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.19806030 |
| 142 | chromatin assembly (GO:0031497) | 2.19453120 |
| 143 | trophectodermal cell differentiation (GO:0001829) | 2.18885023 |
| 144 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.18786785 |
| 145 | negative regulation of cell killing (GO:0031342) | 2.18607637 |
| 146 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.18607637 |
| 147 | interkinetic nuclear migration (GO:0022027) | 2.17494749 |
| 148 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.17049687 |
| 149 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.14926899 |
| 150 | skeletal muscle adaptation (GO:0043501) | 2.13599784 |
| 151 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.12496699 |
| 152 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.12436588 |
| 153 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.11594573 |
| 154 | cortical actin cytoskeleton organization (GO:0030866) | 2.10562161 |
| 155 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.09306256 |
| 156 | positive T cell selection (GO:0043368) | 2.08189215 |
| 157 | hypotonic response (GO:0006971) | 2.04789680 |
| 158 | peptidyl-threonine phosphorylation (GO:0018107) | 2.04075415 |
| 159 | positive regulation by symbiont of host defense response (GO:0052509) | 1.99184707 |
| 160 | modulation by symbiont of host defense response (GO:0052031) | 1.99184707 |
| 161 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 1.99184707 |
| 162 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 1.99184707 |
| 163 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 1.99184707 |
| 164 | modulation by symbiont of host immune response (GO:0052553) | 1.99184707 |
| 165 | establishment of nucleus localization (GO:0040023) | 1.99107968 |
| 166 | cell differentiation in hindbrain (GO:0021533) | 1.98859678 |
| 167 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 1.97100818 |
| 168 | regulation of response to reactive oxygen species (GO:1901031) | 1.95871357 |
| 169 | regulation of gamma-delta T cell activation (GO:0046643) | 1.95866084 |
| 170 | detection of external biotic stimulus (GO:0098581) | 1.95711133 |
| 171 | response to monoamine (GO:0071867) | 1.95710753 |
| 172 | response to catecholamine (GO:0071869) | 1.95710753 |
| 173 | negative regulation of exocytosis (GO:0045920) | 1.95235572 |
| 174 | establishment of protein localization to Golgi (GO:0072600) | 1.94664380 |
| 175 | positive regulation of fibroblast migration (GO:0010763) | 1.94263779 |
| 176 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 1.94134709 |
| 177 | early endosome to late endosome transport (GO:0045022) | 1.93576853 |
| 178 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 1.93046361 |
| 179 | N-terminal protein amino acid acetylation (GO:0006474) | 1.92378739 |
| 180 | negative regulation of anoikis (GO:2000811) | 1.92377912 |
| 181 | protein targeting to Golgi (GO:0000042) | 1.92205920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.08082929 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.96742960 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.46540469 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.19725692 |
| 5 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.14273807 |
| 6 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 3.02800135 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.70204547 |
| 8 | * MYC_22102868_ChIP-Seq_BL_Human | 2.63750871 |
| 9 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.57314120 |
| 10 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.50802041 |
| 11 | * GATA1_19941826_ChIP-Seq_K562_Human | 2.45976430 |
| 12 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.38405269 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.35438228 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.09568778 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.02419309 |
| 16 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.96248196 |
| 17 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.91355632 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88244393 |
| 19 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.83704123 |
| 20 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.82711695 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.80704203 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.77352609 |
| 23 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.77195668 |
| 24 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.70443740 |
| 25 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.69236600 |
| 26 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.69087026 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.67560627 |
| 28 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.61747367 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.60876950 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.58985288 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55569426 |
| 32 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55018077 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.54786167 |
| 34 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.53940003 |
| 35 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.53526791 |
| 36 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.50840069 |
| 37 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.50064506 |
| 38 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.48570064 |
| 39 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.48349064 |
| 40 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.48053418 |
| 41 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.47082222 |
| 42 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.44904671 |
| 43 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.44557090 |
| 44 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.43913930 |
| 45 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.43636658 |
| 46 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.43229793 |
| 47 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.43224881 |
| 48 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.41617934 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.38876249 |
| 50 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.38685401 |
| 51 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.38683254 |
| 52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38028459 |
| 53 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.37515570 |
| 54 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.37188454 |
| 55 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.37119863 |
| 56 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.34218110 |
| 57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.34150971 |
| 58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33545786 |
| 59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.32820386 |
| 60 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.31221664 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.30796664 |
| 62 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.29505997 |
| 63 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.28193686 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27008166 |
| 65 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26981024 |
| 66 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25705556 |
| 67 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.24523530 |
| 68 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24425392 |
| 69 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.24260091 |
| 70 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.23853136 |
| 71 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.22044836 |
| 72 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.21822185 |
| 73 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21758990 |
| 74 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.21707230 |
| 75 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.21194477 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20349744 |
| 77 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20197175 |
| 78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19702641 |
| 79 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.19339123 |
| 80 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18776847 |
| 81 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17644570 |
| 82 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17614260 |
| 83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17173215 |
| 84 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17043597 |
| 85 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.17015914 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16760366 |
| 87 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16694256 |
| 88 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.16314786 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15145130 |
| 90 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.15040180 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14729211 |
| 92 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.14543174 |
| 93 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14316923 |
| 94 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.13455584 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13294055 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13294055 |
| 97 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13009901 |
| 98 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12610320 |
| 99 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.11621907 |
| 100 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.11326029 |
| 101 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.11145921 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10859070 |
| 103 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10465300 |
| 104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10349939 |
| 105 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09652862 |
| 106 | MYB_26560356_Chip-Seq_TH1_Human | 1.08974841 |
| 107 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.08796365 |
| 108 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.08239185 |
| 109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07804281 |
| 110 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07679471 |
| 111 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07215416 |
| 112 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07215416 |
| 113 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05764927 |
| 114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05485201 |
| 115 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.04678841 |
| 116 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04375860 |
| 117 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04352939 |
| 118 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03853005 |
| 119 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03662732 |
| 120 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03640064 |
| 121 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.03633179 |
| 122 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02490590 |
| 123 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01780560 |
| 124 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.00906844 |
| 125 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00562016 |
| 126 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00349655 |
| 127 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.00324832 |
| 128 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00221616 |
| 129 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.99706953 |
| 130 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99683511 |
| 131 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.99229337 |
| 132 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99085259 |
| 133 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.98000847 |
| 134 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.97985402 |
| 135 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.97817884 |
| 136 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.97535463 |
| 137 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.97515420 |
| 138 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97370198 |
| 139 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97297651 |
| 140 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97277762 |
| 141 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.97272353 |
| 142 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.92953266 |
| 143 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92586400 |
| 144 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92213221 |
| 145 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.92200834 |
| 146 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89481639 |
| 147 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88293670 |
| 148 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.87437609 |
| 149 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86469276 |
| 150 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.86403742 |
| 151 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.84468341 |
| 152 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.83981874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 3.96534765 |
| 2 | MP0003303_peritoneal_inflammation | 3.80371139 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 3.65055405 |
| 4 | MP0008260_abnormal_autophagy | 3.51846786 |
| 5 | MP0004147_increased_porphyrin_level | 3.39371679 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.87460591 |
| 7 | MP0002009_preneoplasia | 2.60661595 |
| 8 | MP0001545_abnormal_hematopoietic_system | 2.36344827 |
| 9 | MP0005397_hematopoietic_system_phenotyp | 2.36344827 |
| 10 | MP0005076_abnormal_cell_differentiation | 2.29395913 |
| 11 | MP0003724_increased_susceptibility_to | 2.29320313 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.26317839 |
| 13 | MP0005409_darkened_coat_color | 2.22450779 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.19312052 |
| 15 | MP0004084_abnormal_cardiac_muscle | 2.13391193 |
| 16 | MP0005451_abnormal_body_composition | 2.13171791 |
| 17 | MP0002332_abnormal_exercise_endurance | 2.13110210 |
| 18 | * MP0004808_abnormal_hematopoietic_stem | 2.05448618 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 1.97400156 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 1.96020070 |
| 21 | MP0003172_abnormal_lysosome_physiology | 1.95470462 |
| 22 | MP0003091_abnormal_cell_migration | 1.83883165 |
| 23 | MP0004883_abnormal_blood_vessel | 1.69867093 |
| 24 | * MP0010307_abnormal_tumor_latency | 1.67693381 |
| 25 | MP0006054_spinal_hemorrhage | 1.64388225 |
| 26 | MP0003566_abnormal_cell_adhesion | 1.63134603 |
| 27 | MP0003690_abnormal_glial_cell | 1.62780414 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.61221713 |
| 29 | MP0000015_abnormal_ear_pigmentation | 1.61068355 |
| 30 | MP0008877_abnormal_DNA_methylation | 1.57291509 |
| 31 | MP0005174_abnormal_tail_pigmentation | 1.56330729 |
| 32 | MP0003111_abnormal_nucleus_morphology | 1.56241691 |
| 33 | MP0001915_intracranial_hemorrhage | 1.55476971 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.53921747 |
| 35 | MP0003787_abnormal_imprinting | 1.52187846 |
| 36 | MP0010630_abnormal_cardiac_muscle | 1.48516916 |
| 37 | MP0003329_amyloid_beta_deposits | 1.47970432 |
| 38 | MP0008007_abnormal_cellular_replicative | 1.45177383 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.41031530 |
| 40 | MP0009278_abnormal_bone_marrow | 1.40356169 |
| 41 | MP0005248_abnormal_Harderian_gland | 1.40142292 |
| 42 | MP0003828_pulmonary_edema | 1.33654031 |
| 43 | MP0010094_abnormal_chromosome_stability | 1.33218791 |
| 44 | MP0003941_abnormal_skin_development | 1.33076785 |
| 45 | MP0004484_altered_response_of | 1.32743673 |
| 46 | MP0005164_abnormal_response_to | 1.31596135 |
| 47 | MP0003252_abnormal_bile_duct | 1.30957841 |
| 48 | MP0004381_abnormal_hair_follicle | 1.30396341 |
| 49 | MP0002086_abnormal_extraembryonic_tissu | 1.28919792 |
| 50 | MP0003943_abnormal_hepatobiliary_system | 1.28149691 |
| 51 | MP0004510_myositis | 1.27805983 |
| 52 | MP0000767_abnormal_smooth_muscle | 1.25818427 |
| 53 | MP0003077_abnormal_cell_cycle | 1.25445205 |
| 54 | MP0003567_abnormal_fetal_cardiomyocyte | 1.24962061 |
| 55 | MP0000350_abnormal_cell_proliferation | 1.22056151 |
| 56 | MP0010368_abnormal_lymphatic_system | 1.21490425 |
| 57 | MP0008004_abnormal_stomach_pH | 1.20828995 |
| 58 | MP0003984_embryonic_growth_retardation | 1.18426698 |
| 59 | MP0002088_abnormal_embryonic_growth/wei | 1.17650298 |
| 60 | MP0002971_abnormal_brown_adipose | 1.17349934 |
| 61 | MP0003221_abnormal_cardiomyocyte_apopto | 1.16188573 |
| 62 | MP0006138_congestive_heart_failure | 1.15690923 |
| 63 | MP0003045_fibrosis | 1.15212620 |
| 64 | MP0008961_abnormal_basal_metabolism | 1.14960279 |
| 65 | MP0005380_embryogenesis_phenotype | 1.14448290 |
| 66 | MP0001672_abnormal_embryogenesis/_devel | 1.14448290 |
| 67 | MP0008438_abnormal_cutaneous_collagen | 1.11641983 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.11171215 |
| 69 | MP0005023_abnormal_wound_healing | 1.10497854 |
| 70 | MP0004197_abnormal_fetal_growth/weight/ | 1.10372689 |
| 71 | MP0009780_abnormal_chondrocyte_physiolo | 1.10259343 |
| 72 | MP0003632_abnormal_nervous_system | 1.08238918 |
| 73 | MP0005666_abnormal_adipose_tissue | 1.07823351 |
| 74 | MP0005275_abnormal_skin_tensile | 1.07162781 |
| 75 | MP0000266_abnormal_heart_morphology | 1.06606775 |
| 76 | MP0002006_tumorigenesis | 1.03913218 |
| 77 | MP0004782_abnormal_surfactant_physiolog | 1.02396981 |
| 78 | MP0005187_abnormal_penis_morphology | 1.02307235 |
| 79 | MP0001544_abnormal_cardiovascular_syste | 1.01291406 |
| 80 | MP0005385_cardiovascular_system_phenoty | 1.01291406 |
| 81 | MP0003115_abnormal_respiratory_system | 1.00672660 |
| 82 | MP0008775_abnormal_heart_ventricle | 0.99749594 |
| 83 | MP0002925_abnormal_cardiovascular_devel | 0.98990024 |
| 84 | MP0003879_abnormal_hair_cell | 0.98284098 |
| 85 | MP0004087_abnormal_muscle_fiber | 0.97939775 |
| 86 | MP0003631_nervous_system_phenotype | 0.97288040 |
| 87 | MP0001697_abnormal_embryo_size | 0.97227403 |
| 88 | MP0000490_abnormal_crypts_of | 0.96735877 |
| 89 | MP0005375_adipose_tissue_phenotype | 0.95065406 |
| 90 | MP0000383_abnormal_hair_follicle | 0.94676319 |
| 91 | * MP0004947_skin_inflammation | 0.94283727 |
| 92 | MP0002139_abnormal_hepatobiliary_system | 0.93516923 |
| 93 | MP0004036_abnormal_muscle_relaxation | 0.92083767 |
| 94 | MP0001849_ear_inflammation | 0.91816548 |
| 95 | MP0002998_abnormal_bone_remodeling | 0.91706452 |
| 96 | MP0003279_aneurysm | 0.91669779 |
| 97 | MP0000604_amyloidosis | 0.91202830 |
| 98 | MP0000733_abnormal_muscle_development | 0.90834244 |
| 99 | MP0009053_abnormal_anal_canal | 0.90637674 |
| 100 | MP0005367_renal/urinary_system_phenotyp | 0.89827220 |
| 101 | MP0000516_abnormal_urinary_system | 0.89827220 |
| 102 | MP0001958_emphysema | 0.88713641 |
| 103 | MP0002084_abnormal_developmental_patter | 0.88585287 |
| 104 | MP0001440_abnormal_grooming_behavior | 0.88430502 |
| 105 | * MP0001119_abnormal_female_reproductive | 0.87798926 |
| 106 | MP0004885_abnormal_endolymph | 0.87676744 |
| 107 | MP0002108_abnormal_muscle_morphology | 0.87581490 |
| 108 | * MP0003699_abnormal_female_reproductive | 0.87518194 |
| 109 | MP0005388_respiratory_system_phenotype | 0.87473750 |
| 110 | MP0002133_abnormal_respiratory_system | 0.87473750 |
| 111 | MP0003646_muscle_fatigue | 0.86669295 |
| 112 | MP0003633_abnormal_nervous_system | 0.86323440 |
| 113 | MP0000569_abnormal_digit_pigmentation | 0.86263574 |
| 114 | MP0004130_abnormal_muscle_cell | 0.85993755 |
| 115 | MP0001851_eye_inflammation | 0.85551701 |
| 116 | MP0002928_abnormal_bile_duct | 0.84886308 |
| 117 | MP0002060_abnormal_skin_morphology | 0.83948027 |
| 118 | MP0005647_abnormal_sex_gland | 0.83519561 |
| 119 | MP0005408_hypopigmentation | 0.83195747 |
| 120 | * MP0000313_abnormal_cell_death | 0.82916818 |
| 121 | MP0005083_abnormal_biliary_tract | 0.82583905 |
| 122 | MP0002168_other_aberrant_phenotype | 0.81928484 |
| 123 | MP0002128_abnormal_blood_circulation | 0.81693035 |
| 124 | MP0010678_abnormal_skin_adnexa | 0.81464945 |
| 125 | MP0002653_abnormal_ependyma_morphology | 0.81281215 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.79104459 |
| 127 | MP0000749_muscle_degeneration | 0.78725560 |
| 128 | MP0000371_diluted_coat_color | 0.78445662 |
| 129 | MP0003634_abnormal_glial_cell | 0.78419947 |
| 130 | MP0003453_abnormal_keratinocyte_physiol | 0.78218923 |
| 131 | MP0003436_decreased_susceptibility_to | 0.77881374 |
| 132 | MP0009703_decreased_birth_body | 0.77035028 |
| 133 | MP0000534_abnormal_ureter_morphology | 0.76881475 |
| 134 | MP0002085_abnormal_embryonic_tissue | 0.75885284 |
| 135 | MP0000609_abnormal_liver_physiology | 0.75349872 |
| 136 | * MP0002019_abnormal_tumor_incidence | 0.74707680 |
| 137 | MP0005621_abnormal_cell_physiology | 0.74660172 |
| 138 | MP0009384_cardiac_valve_regurgitation | 0.74588487 |
| 139 | MP0000598_abnormal_liver_morphology | 0.74322868 |
| 140 | MP0005503_abnormal_tendon_morphology | 0.73925143 |
| 141 | MP0001175_abnormal_lung_morphology | 0.73380619 |
| 142 | MP0002972_abnormal_cardiac_muscle | 0.73157304 |
| 143 | * MP0002398_abnormal_bone_marrow | 0.73033381 |
| 144 | MP0001784_abnormal_fluid_regulation | 0.72868336 |
| 145 | MP0005620_abnormal_muscle_contractility | 0.72514595 |
| 146 | MP0000759_abnormal_skeletal_muscle | 0.72474101 |
| 147 | MP0002269_muscular_atrophy | 0.71444414 |
| 148 | MP0002419_abnormal_innate_immunity | 0.70954286 |
| 149 | MP0001502_abnormal_circadian_rhythm | 0.69539792 |
| 150 | MP0009115_abnormal_fat_cell | 0.68772782 |
| 151 | MP0002822_catalepsy | 0.64572315 |
| 152 | MP0000465_gastrointestinal_hemorrhage | 0.62381686 |
| 153 | MP0004185_abnormal_adipocyte_glucose | 0.62197432 |
| 154 | MP0001501_abnormal_sleep_pattern | 0.59660704 |
| 155 | MP0003075_altered_response_to | 0.58234999 |
| 156 | MP0004043_abnormal_pH_regulation | 0.57484706 |
| 157 | MP0003763_abnormal_thymus_physiology | 0.56488598 |
| 158 | MP0000685_abnormal_immune_system | 0.55866850 |
| 159 | MP0005025_abnormal_response_to | 0.55059226 |
| 160 | MP0000249_abnormal_blood_vessel | 0.54513572 |
| 161 | MP0001664_abnormal_digestion | 0.54292435 |
| 162 | MP0005167_abnormal_blood-brain_barrier | 0.54154449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Poikilocytosis (HP:0004447) | 5.13176590 |
| 2 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.69961435 |
| 3 | Abnormality of the fingertips (HP:0001211) | 4.54626924 |
| 4 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.65649207 |
| 5 | Hypochromic microcytic anemia (HP:0004840) | 3.52862589 |
| 6 | Dysmetric saccades (HP:0000641) | 3.35640464 |
| 7 | Acanthocytosis (HP:0001927) | 3.06163200 |
| 8 | Enlarged penis (HP:0000040) | 2.97310448 |
| 9 | Slow saccadic eye movements (HP:0000514) | 2.95889135 |
| 10 | Papillary thyroid carcinoma (HP:0002895) | 2.94704973 |
| 11 | Postural instability (HP:0002172) | 2.93565823 |
| 12 | Obstructive sleep apnea (HP:0002870) | 2.87175609 |
| 13 | Cerebral inclusion bodies (HP:0100314) | 2.82552019 |
| 14 | Reticulocytosis (HP:0001923) | 2.79865800 |
| 15 | Peritonitis (HP:0002586) | 2.71190930 |
| 16 | Lip pit (HP:0100267) | 2.69189371 |
| 17 | Long eyelashes (HP:0000527) | 2.63617968 |
| 18 | Acute myeloid leukemia (HP:0004808) | 2.62714208 |
| 19 | Abnormality of incisor morphology (HP:0011063) | 2.61467343 |
| 20 | Visual hallucinations (HP:0002367) | 2.57521201 |
| 21 | Difficulty running (HP:0009046) | 2.54134582 |
| 22 | Microcytic anemia (HP:0001935) | 2.52075195 |
| 23 | Gastrointestinal infarctions (HP:0005244) | 2.51357793 |
| 24 | Diaphragmatic weakness (HP:0009113) | 2.45055511 |
| 25 | Broad palm (HP:0001169) | 2.44023806 |
| 26 | Aortic aneurysm (HP:0004942) | 2.41408210 |
| 27 | Hyperkalemia (HP:0002153) | 2.41071874 |
| 28 | Overgrowth (HP:0001548) | 2.39995078 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 2.38030345 |
| 30 | Spinal cord lesions (HP:0100561) | 2.33398331 |
| 31 | Syringomyelia (HP:0003396) | 2.33398331 |
| 32 | Macroorchidism (HP:0000053) | 2.32368336 |
| 33 | Eczematoid dermatitis (HP:0000976) | 2.31276932 |
| 34 | Gingival bleeding (HP:0000225) | 2.29052455 |
| 35 | Ankle contracture (HP:0006466) | 2.27965109 |
| 36 | Deep philtrum (HP:0002002) | 2.27312721 |
| 37 | Narrow palate (HP:0000189) | 2.25285983 |
| 38 | Muscle fiber splitting (HP:0003555) | 2.22961971 |
| 39 | Gingivitis (HP:0000230) | 2.22651552 |
| 40 | Thyroid carcinoma (HP:0002890) | 2.21802218 |
| 41 | Bundle branch block (HP:0011710) | 2.18840486 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.14008840 |
| 43 | Shawl scrotum (HP:0000049) | 2.13940523 |
| 44 | Polycythemia (HP:0001901) | 2.13509147 |
| 45 | Hematochezia (HP:0002573) | 2.11513915 |
| 46 | Optic neuritis (HP:0100653) | 2.10489725 |
| 47 | Retrobulbar optic neuritis (HP:0100654) | 2.10489725 |
| 48 | Arterial tortuosity (HP:0005116) | 2.09753797 |
| 49 | Orchitis (HP:0100796) | 2.09389618 |
| 50 | Vascular tortuosity (HP:0004948) | 2.08122545 |
| 51 | Absent frontal sinuses (HP:0002688) | 2.05514688 |
| 52 | Hyporeflexia of lower limbs (HP:0002600) | 2.05235904 |
| 53 | Rectal prolapse (HP:0002035) | 2.03727925 |
| 54 | Cerebral aneurysm (HP:0004944) | 2.03690897 |
| 55 | Febrile seizures (HP:0002373) | 2.03651638 |
| 56 | Depressed nasal tip (HP:0000437) | 2.03624135 |
| 57 | Hyperacusis (HP:0010780) | 2.03251629 |
| 58 | Cholelithiasis (HP:0001081) | 2.02961242 |
| 59 | Progressive cerebellar ataxia (HP:0002073) | 1.99669860 |
| 60 | Neonatal hypoglycemia (HP:0001998) | 1.96942156 |
| 61 | Insomnia (HP:0100785) | 1.96622535 |
| 62 | Heterotopia (HP:0002282) | 1.96167329 |
| 63 | Subacute progressive viral hepatitis (HP:0006572) | 1.95886802 |
| 64 | Abnormality of the nasal septum (HP:0000419) | 1.92549097 |
| 65 | Shallow orbits (HP:0000586) | 1.92213112 |
| 66 | Aneurysm (HP:0002617) | 1.90022491 |
| 67 | Osteomalacia (HP:0002749) | 1.89719401 |
| 68 | Increased variability in muscle fiber diameter (HP:0003557) | 1.89581564 |
| 69 | Facial diplegia (HP:0001349) | 1.89002118 |
| 70 | Prominent nose (HP:0000448) | 1.87956507 |
| 71 | Urethral obstruction (HP:0000796) | 1.86030084 |
| 72 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.85291923 |
| 73 | Short 4th metacarpal (HP:0010044) | 1.85291923 |
| 74 | Recurrent abscess formation (HP:0002722) | 1.84792327 |
| 75 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.84594967 |
| 76 | Subaortic stenosis (HP:0001682) | 1.84594967 |
| 77 | Osteolytic defects of the hand bones (HP:0009699) | 1.84592877 |
| 78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.84592877 |
| 79 | Renovascular hypertension (HP:0100817) | 1.84275802 |
| 80 | Keratoconjunctivitis sicca (HP:0001097) | 1.82738904 |
| 81 | Right ventricular cardiomyopathy (HP:0011663) | 1.82368865 |
| 82 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.81358816 |
| 83 | Male infertility (HP:0003251) | 1.80938713 |
| 84 | Prolonged bleeding time (HP:0003010) | 1.80228383 |
| 85 | Broad metatarsal (HP:0001783) | 1.79988684 |
| 86 | Atrial fibrillation (HP:0005110) | 1.78266528 |
| 87 | Myositis (HP:0100614) | 1.77048808 |
| 88 | Hepatocellular carcinoma (HP:0001402) | 1.75677982 |
| 89 | Neoplasm of the oral cavity (HP:0100649) | 1.75293044 |
| 90 | Truncal obesity (HP:0001956) | 1.75037386 |
| 91 | Mitral valve prolapse (HP:0001634) | 1.74954152 |
| 92 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.74505226 |
| 93 | Hyperbilirubinemia (HP:0002904) | 1.74416246 |
| 94 | Cutaneous melanoma (HP:0012056) | 1.74057692 |
| 95 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.72898349 |
| 96 | Mask-like facies (HP:0000298) | 1.71456987 |
| 97 | Increased connective tissue (HP:0009025) | 1.70662362 |
| 98 | Abnormality of the radial head (HP:0003995) | 1.69673427 |
| 99 | Tapered finger (HP:0001182) | 1.69524360 |
| 100 | Hypochromic anemia (HP:0001931) | 1.69510924 |
| 101 | Sandal gap (HP:0001852) | 1.67922678 |
| 102 | Neoplasm of the adrenal cortex (HP:0100641) | 1.67799421 |
| 103 | Trigonocephaly (HP:0000243) | 1.67378218 |
| 104 | Asymmetry of the thorax (HP:0001555) | 1.67198306 |
| 105 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.67111389 |
| 106 | Hyperventilation (HP:0002883) | 1.66900275 |
| 107 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.66405712 |
| 108 | Ventricular tachycardia (HP:0004756) | 1.65838740 |
| 109 | Periodontitis (HP:0000704) | 1.65798535 |
| 110 | Long toe (HP:0010511) | 1.65583863 |
| 111 | Subcapsular cataract (HP:0000523) | 1.63666241 |
| 112 | High pitched voice (HP:0001620) | 1.63650612 |
| 113 | Abnormal gallbladder morphology (HP:0012437) | 1.63277271 |
| 114 | Renal tubular acidosis (HP:0001947) | 1.62741443 |
| 115 | Spondylolisthesis (HP:0003302) | 1.62010179 |
| 116 | Genetic anticipation (HP:0003743) | 1.61292351 |
| 117 | Protrusio acetabuli (HP:0003179) | 1.59261884 |
| 118 | Hyperglycemia (HP:0003074) | 1.58203555 |
| 119 | Dislocated radial head (HP:0003083) | 1.58196040 |
| 120 | Posterior subcapsular cataract (HP:0007787) | 1.58150154 |
| 121 | Myocardial infarction (HP:0001658) | 1.57981473 |
| 122 | Decreased motor nerve conduction velocity (HP:0003431) | 1.57829719 |
| 123 | Metaphyseal cupping (HP:0003021) | 1.57604472 |
| 124 | Hypoplasia of the iris (HP:0007676) | 1.56515508 |
| 125 | Elfin facies (HP:0004428) | 1.56407375 |
| 126 | Abnormality of the 4th metacarpal (HP:0010012) | 1.56374698 |
| 127 | Ankle clonus (HP:0011448) | 1.56004632 |
| 128 | Primary atrial arrhythmia (HP:0001692) | 1.55113712 |
| 129 | Laryngomalacia (HP:0001601) | 1.54947583 |
| 130 | Epistaxis (HP:0000421) | 1.54721023 |
| 131 | Volvulus (HP:0002580) | 1.54024248 |
| 132 | Hypoplastic labia majora (HP:0000059) | 1.53512951 |
| 133 | Impaired platelet aggregation (HP:0003540) | 1.53444202 |
| 134 | Abnormal platelet function (HP:0011869) | 1.53444202 |
| 135 | Widely spaced teeth (HP:0000687) | 1.53379828 |
| 136 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.53168567 |
| 137 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.52505452 |
| 138 | Childhood onset (HP:0011463) | 1.51518681 |
| 139 | Lymphangioma (HP:0100764) | 1.51510494 |
| 140 | Bladder carcinoma (HP:0002862) | 1.51390798 |
| 141 | Bladder neoplasm (HP:0009725) | 1.51390798 |
| 142 | Abnormality of the ischium (HP:0003174) | 1.51227107 |
| 143 | Onion bulb formation (HP:0003383) | 1.50975839 |
| 144 | Keratoconjunctivitis (HP:0001096) | 1.50482522 |
| 145 | Abnormal hair whorl (HP:0010721) | 1.50416363 |
| 146 | Abnormality of the labia majora (HP:0012881) | 1.49899918 |
| 147 | Germ cell neoplasia (HP:0100728) | 1.49246155 |
| 148 | Papilledema (HP:0001085) | 1.49214483 |
| 149 | Abnormality of saccadic eye movements (HP:0000570) | 1.48674733 |
| 150 | Testicular neoplasm (HP:0010788) | 1.47507158 |
| 151 | Pseudobulbar signs (HP:0002200) | 1.47434469 |
| 152 | Striae distensae (HP:0001065) | 1.46689264 |
| 153 | Large earlobe (HP:0009748) | 1.46586335 |
| 154 | Hypoplastic ischia (HP:0003175) | 1.46218418 |
| 155 | Pendular nystagmus (HP:0012043) | 1.45554397 |
| 156 | Curly hair (HP:0002212) | 1.45465294 |
| 157 | Cystic hygroma (HP:0000476) | 1.45425257 |
| 158 | Pigmentary retinal degeneration (HP:0001146) | 1.45277292 |
| 159 | Acute lymphatic leukemia (HP:0006721) | 1.45202626 |
| 160 | Truncal ataxia (HP:0002078) | 1.44638268 |
| 161 | Cubitus valgus (HP:0002967) | 1.44565284 |
| 162 | Coarse hair (HP:0002208) | 1.44361792 |
| 163 | Gastrointestinal carcinoma (HP:0002672) | 1.44229634 |
| 164 | Type 1 muscle fiber predominance (HP:0003803) | 1.44168525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 3.94108359 |
| 2 | CDK12 | 3.92649959 |
| 3 | LATS1 | 3.84218468 |
| 4 | PKN2 | 2.55663875 |
| 5 | WNK1 | 2.50720989 |
| 6 | RIPK1 | 2.36624771 |
| 7 | MAP3K3 | 2.17795475 |
| 8 | TRIB3 | 2.16606789 |
| 9 | MARK2 | 1.97324253 |
| 10 | TAOK3 | 1.94623340 |
| 11 | SIK1 | 1.88907882 |
| 12 | FGFR3 | 1.86938930 |
| 13 | STK3 | 1.84749630 |
| 14 | STK38L | 1.73614522 |
| 15 | MAP3K2 | 1.68988118 |
| 16 | FRK | 1.64976767 |
| 17 | TRPM7 | 1.61737965 |
| 18 | ZAK | 1.61443402 |
| 19 | CDK6 | 1.54553802 |
| 20 | FGR | 1.52341303 |
| 21 | STK24 | 1.52202553 |
| 22 | FLT3 | 1.52040065 |
| 23 | GRK6 | 1.48746154 |
| 24 | PTK2B | 1.46144192 |
| 25 | MAP3K1 | 1.44222040 |
| 26 | DMPK | 1.41274186 |
| 27 | CDK9 | 1.41183301 |
| 28 | BLK | 1.40061176 |
| 29 | MAPKAPK3 | 1.39535487 |
| 30 | * SGK3 | 1.38494984 |
| 31 | RIPK4 | 1.32472809 |
| 32 | TAOK1 | 1.31434213 |
| 33 | PDGFRA | 1.30070125 |
| 34 | CAMK1D | 1.29502188 |
| 35 | AKT3 | 1.27261854 |
| 36 | RPS6KB2 | 1.26999198 |
| 37 | * SGK223 | 1.24138260 |
| 38 | * SGK494 | 1.24138260 |
| 39 | BRD4 | 1.21788192 |
| 40 | IRAK1 | 1.21610490 |
| 41 | TGFBR2 | 1.21505680 |
| 42 | IRAK2 | 1.21358996 |
| 43 | GRK5 | 1.21208589 |
| 44 | NEK9 | 1.20899891 |
| 45 | NEK2 | 1.19587236 |
| 46 | KSR1 | 1.18496622 |
| 47 | NLK | 1.16916226 |
| 48 | MAP3K10 | 1.16809668 |
| 49 | TTN | 1.13338994 |
| 50 | TAOK2 | 1.08771102 |
| 51 | PRKAA1 | 1.08018506 |
| 52 | CDC7 | 1.07489134 |
| 53 | PIK3CG | 1.07109839 |
| 54 | KSR2 | 1.06339522 |
| 55 | NEK1 | 1.05887038 |
| 56 | * SGK2 | 1.04923435 |
| 57 | DYRK1A | 1.03324374 |
| 58 | MTOR | 1.02020069 |
| 59 | STK11 | 1.01556403 |
| 60 | CSK | 1.00527720 |
| 61 | DAPK2 | 0.97890860 |
| 62 | CDK4 | 0.97765825 |
| 63 | LATS2 | 0.97660804 |
| 64 | NTRK3 | 0.97456978 |
| 65 | STK38 | 0.95915265 |
| 66 | PTK6 | 0.93252036 |
| 67 | LMTK2 | 0.92499741 |
| 68 | YES1 | 0.89782149 |
| 69 | * CHUK | 0.86894307 |
| 70 | MAP3K13 | 0.85861887 |
| 71 | * PIM1 | 0.85430154 |
| 72 | PDGFRB | 0.84814427 |
| 73 | * SGK1 | 0.82551267 |
| 74 | ICK | 0.80723543 |
| 75 | MAP3K6 | 0.80628424 |
| 76 | MAPK7 | 0.80441201 |
| 77 | RET | 0.80307794 |
| 78 | JAK2 | 0.80167652 |
| 79 | MAPK12 | 0.80079845 |
| 80 | PLK2 | 0.79873947 |
| 81 | PRPF4B | 0.79734686 |
| 82 | BRSK2 | 0.78719127 |
| 83 | STK10 | 0.77589896 |
| 84 | SCYL2 | 0.77150876 |
| 85 | MAP3K11 | 0.76339441 |
| 86 | PAK3 | 0.76007072 |
| 87 | EPHB1 | 0.74787144 |
| 88 | CDC42BPA | 0.73918253 |
| 89 | MATK | 0.73023607 |
| 90 | CAMKK2 | 0.73011219 |
| 91 | RPS6KB1 | 0.72444460 |
| 92 | CAMK1 | 0.72338351 |
| 93 | IRAK4 | 0.72088205 |
| 94 | TTK | 0.70829416 |
| 95 | PRKD2 | 0.70659209 |
| 96 | JAK1 | 0.70026627 |
| 97 | ERBB2 | 0.69396506 |
| 98 | BMX | 0.68238395 |
| 99 | CAMK4 | 0.67455928 |
| 100 | SYK | 0.66793669 |
| 101 | EPHA3 | 0.66493821 |
| 102 | HCK | 0.66244940 |
| 103 | RPS6KA6 | 0.65386219 |
| 104 | MKNK2 | 0.64737483 |
| 105 | HIPK2 | 0.64484534 |
| 106 | PRKCH | 0.63697639 |
| 107 | DYRK1B | 0.63362220 |
| 108 | MAP2K3 | 0.63286455 |
| 109 | MARK3 | 0.62721809 |
| 110 | MARK1 | 0.62538175 |
| 111 | RPS6KC1 | 0.62440024 |
| 112 | RPS6KL1 | 0.62440024 |
| 113 | CAMK1G | 0.61133292 |
| 114 | RPS6KA2 | 0.61078373 |
| 115 | TNK2 | 0.61040616 |
| 116 | MKNK1 | 0.60960313 |
| 117 | CHEK2 | 0.60639569 |
| 118 | ATM | 0.59727619 |
| 119 | ERN1 | 0.59660045 |
| 120 | PAK4 | 0.58583065 |
| 121 | MAPK11 | 0.58042183 |
| 122 | FES | 0.56829886 |
| 123 | OBSCN | 0.56604981 |
| 124 | EPHA2 | 0.56531941 |
| 125 | RAF1 | 0.56072988 |
| 126 | CDK7 | 0.55858285 |
| 127 | JAK3 | 0.55692942 |
| 128 | MAP3K7 | 0.55105745 |
| 129 | MAP3K14 | 0.54072612 |
| 130 | MAP2K4 | 0.53719980 |
| 131 | MAP3K5 | 0.52914684 |
| 132 | PDK1 | 0.52484063 |
| 133 | ATR | 0.52136695 |
| 134 | ALK | 0.51324153 |
| 135 | MOS | 0.51190600 |
| 136 | ZAP70 | 0.51187883 |
| 137 | PINK1 | 0.51030797 |
| 138 | NUAK1 | 0.50470084 |
| 139 | MUSK | 0.50100581 |
| 140 | * AKT1 | 0.49589167 |
| 141 | * STK4 | 0.48222394 |
| 142 | TYK2 | 0.46780345 |
| 143 | PIK3CA | 0.46434145 |
| 144 | * MAPK14 | 0.46385348 |
| 145 | KIT | 0.45923639 |
| 146 | MELK | 0.45562101 |
| 147 | PDPK1 | 0.45381982 |
| 148 | CAMKK1 | 0.45376797 |
| 149 | CDK2 | 0.45353294 |
| 150 | CDK8 | 0.45197527 |
| 151 | RPS6KA1 | 0.45112749 |
| 152 | MAP4K1 | 0.43888660 |
| 153 | MAPK8 | 0.43525486 |
| 154 | * MAPK1 | 0.43418342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lysine degradation_Homo sapiens_hsa00310 | 2.03326642 |
| 2 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.84750834 |
| 3 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.61023197 |
| 4 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.52135180 |
| 5 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.49932278 |
| 6 | Malaria_Homo sapiens_hsa05144 | 1.49720022 |
| 7 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.49121605 |
| 8 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.47500092 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.47190277 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.44377527 |
| 11 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.38269330 |
| 12 | Adherens junction_Homo sapiens_hsa04520 | 1.38191379 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.37229497 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 1.31623086 |
| 15 | Thyroid cancer_Homo sapiens_hsa05216 | 1.29786589 |
| 16 | Insulin resistance_Homo sapiens_hsa04931 | 1.27996922 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.26247815 |
| 18 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.25976310 |
| 19 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.25221047 |
| 20 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.25144642 |
| 21 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.23460278 |
| 22 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.21806971 |
| 23 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.20207995 |
| 24 | Glioma_Homo sapiens_hsa05214 | 1.19999128 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19470207 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.18801078 |
| 27 | ABC transporters_Homo sapiens_hsa02010 | 1.18357830 |
| 28 | * Endometrial cancer_Homo sapiens_hsa05213 | 1.17963036 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15090409 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.13774248 |
| 31 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.13511231 |
| 32 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 1.10917702 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.08611455 |
| 34 | Circadian rhythm_Homo sapiens_hsa04710 | 1.08564195 |
| 35 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.08395758 |
| 36 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.08387540 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.07695001 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05648592 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05631563 |
| 40 | Prostate cancer_Homo sapiens_hsa05215 | 1.05426455 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 1.04503717 |
| 42 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.04111523 |
| 43 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.03810404 |
| 44 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.01544504 |
| 45 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01212801 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00909882 |
| 47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00469393 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00200227 |
| 49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.99347101 |
| 50 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.96826294 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.95253473 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 0.95082228 |
| 53 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.94953383 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.94820531 |
| 55 | Leishmaniasis_Homo sapiens_hsa05140 | 0.93567299 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92282544 |
| 57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91994083 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91853777 |
| 59 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.91685668 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 0.91353372 |
| 61 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.91039500 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.90947325 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.90361162 |
| 64 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.89620618 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88712729 |
| 66 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.88651128 |
| 67 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88559139 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.88460179 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.88432138 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.85853980 |
| 71 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85239213 |
| 72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.84601748 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84263785 |
| 74 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.84148165 |
| 75 | Apoptosis_Homo sapiens_hsa04210 | 0.82403318 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.82058145 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80933541 |
| 78 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.80684265 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79599188 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.79056942 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78234411 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77084354 |
| 83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76286402 |
| 84 | Melanoma_Homo sapiens_hsa05218 | 0.76210116 |
| 85 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74983541 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74670316 |
| 87 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.73982460 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73950573 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73726449 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73365201 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72179005 |
| 92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71600621 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71149163 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.70682895 |
| 95 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.70486229 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69448488 |
| 97 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.68868103 |
| 98 | Circadian entrainment_Homo sapiens_hsa04713 | 0.68473471 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68434006 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67913254 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67743630 |
| 102 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67204185 |
| 103 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.66049510 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.65109364 |
| 105 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64671761 |
| 106 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64664872 |
| 107 | Gap junction_Homo sapiens_hsa04540 | 0.64625609 |
| 108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.64572489 |
| 109 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.64344569 |
| 110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63782065 |
| 111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.63473275 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63243813 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62865712 |
| 114 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62721356 |
| 115 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62654362 |
| 116 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62082468 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61653838 |
| 118 | Influenza A_Homo sapiens_hsa05164 | 0.61019401 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60852611 |
| 120 | Alcoholism_Homo sapiens_hsa05034 | 0.60681988 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58520592 |
| 122 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57075056 |
| 123 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54399485 |
| 124 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.53466346 |
| 125 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.52347112 |
| 126 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.51841585 |
| 127 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50651192 |
| 128 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50485048 |
| 129 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50206129 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.49981532 |
| 131 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49653899 |
| 132 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49096379 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48657400 |
| 134 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.47406642 |
| 135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45061839 |
| 136 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43257816 |
| 137 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.43101550 |
| 138 | Measles_Homo sapiens_hsa05162 | 0.42614309 |

